These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1958747)

  • 1. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.
    Verhoef GE; De Wolf-Peeters C; Ferrant A; Deprez S; Meeus P; Stul M; Zacheé P; Cassiman JJ; Van den Berghe H; Boogaerts MA
    Ann Hematol; 1991 Nov; 63(5):235-41. PubMed ID: 1958747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
    Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
    Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.
    Dickstein JI; Vardiman JW
    Am J Clin Pathol; 1993 Apr; 99(4):513-25. PubMed ID: 8475918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis.
    Ohyashiki K; Sasao I; Ohyashiki JH; Murakami T; Iwabuchi A; Tauchi T; Saito M; Nakazawa S; Serizawa H; Ebihara Y
    Cancer; 1991 Jul; 68(1):178-83. PubMed ID: 2049740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
    Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
    Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mixed myelodysplastic and myeloproliferative syndromes].
    Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
    Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity?
    Solé F; Torrabadella M; Granada I; Florensa L; Vallespi T; Ribera JM; Irriguible D; Milla F; Woessner S
    Leuk Res; 1993 Aug; 17(8):717-20. PubMed ID: 8355516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O
    Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
    Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
    Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course.
    McClure RF; Dewald GW; Hoyer JD; Hanson CA
    Br J Haematol; 1999 Aug; 106(2):445-54. PubMed ID: 10460605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
    Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
    Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.
    Yip SF; So CC; Chan AY; Liu HY; Wan TsK; Chan LC
    Leukemia; 2006 Jun; 20(6):1165. PubMed ID: 16572200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.